The U.S. Food and Drug Administration approved the first therapy in its class to reduce the frequency of bone marrow suppression induced by chemotherapy for extensive-stage small cell lung cancer, the agency announced Friday.
Feb 19, 2021
0
2
(HealthDay)—An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds.
Jan 15, 2021
0
2
(HealthDay)—Inhaled treprostinil improves exercise capacity in patients with pulmonary hypertension due to interstitial lung disease, according to a study published online Jan. 13 in the New England Journal of Medicine.
Jan 14, 2021
0
8
The latest clinical practice guideline on home oxygen therapy addresses long-term and ambulatory oxygen therapy for adults with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) and includes ...
Nov 18, 2020
0
1
A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies—despite the increased risk of adverse outcomes—provided they have close monitoring ...
Nov 6, 2020
0
1
Autoimmune disease is fundamentally a mystery: whyever should an organism systematically set out to harm itself? Now, researchers at the University of Tsukuba have identified a genetic basis for anti-neutrophil cytoplasmic ...
Nov 4, 2020
0
2
More than 30 years after the last guidance on the clinical evaluation of hypersensitivity pneumonitis (HP), the American Thoracic Society—in collaboration with the Asociación Latinoamericana de Tórax or ALAT and the Japanese ...
Aug 3, 2020
0
1
More research must be done to investigate the role of air pollution on the epigenome in patients with interstitial lung diseases (ILDs), in order to develop strategies that minimize the effects of these pollutants, according ...
Jul 1, 2020
0
1
There has been an increase in deaths and disability due to chronic respiratory (lung) diseases over the past three decades, finds an analysis of data from 195 countries published by The BMJ today.
Feb 19, 2020
0
2
(HealthDay)—Piqray (alpelisib) tablets were approved for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer in ...
May 28, 2019
0
1
